![Maya Martinez-Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maya Martinez-Davis
Director/Board Member at
PERSPECTIVE THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
Maya Martinez-Davis is currently an Independent Director at Perspective Therapeutics, Inc. since 2025 and President-US Pharmaceuticals at GSK Plc since 2020.
Former roles include Independent Director at Mirati Therapeutics, Inc. from 2018 to 2024 and President-Biopharma Latin America at Merck KGaA from 2016 to 2019.
Education includes undergraduate studies at St. Louis University and graduate studies at Instituto de Empresa SL.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Maya Martinez-Davis active positions
| Companies | Position | Start |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/01/2020 |
| PERSPECTIVE THERAPEUTICS, INC. | Director/Board Member | 03/09/2025 |
Former positions of Maya Martinez-Davis
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Director/Board Member | 23/01/2024 |
| MERCK KGAA | Corporate Officer/Principal | 01/08/2019 |
Training of Maya Martinez-Davis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
 Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
- Stock Market
- Insiders
- Maya Martinez-Davis
